Navigation Links
Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
Date:7/9/2012

PARIS, July 9, 2012 /PRNewswire/ -- Inspiration Biopharmaceuticals, Inc. (Inspiration) today reported data from its ongoing Phase 2/3 study evaluating the efficacy of OBI-1, an investigational recombinant porcine factor VIII (FVIII), for the treatment of serious bleeds in people with acquired hemophilia A. According to the interim analysis, seven out of seven trial participants receiving OBI-1 experienced control and subsequent resolution of their bleeds. Edward Gomperts, MD, Attending Hematologist and Director of Clinical Research, Clinical Investigation Center at Children's Hospital Los Angeles and Consultant to Inspiration, presented the findings in an oral presentation at the 2012 World Federation of Hemophilia (WFH) World Congress in Paris.

Acquired hemophilia A is a rare, sometimes life-threatening bleeding disorder that is caused by the development of autoantibodies (inhibitors) against FVIII, a key protein contributing to normal coagulation of blood. The antibodies render the native factor VIII ineffective in promoting clotting. Treatment of acquired hemophilia can be challenging, because the antibodies will attack any human form of FVIII. OBI-1 is designed to avoid recognition by antibodies to human FVIII. People with inhibitors to human FVIII may respond to porcine FVIII, replacing the missing step in their coagulation cascade."People with acquired hemophilia currently have limited treatment options to control serious bleeding episodes. These preliminary findings are encouraging and suggest that further investigation of the efficacy and safety of OBI-1 in this population is warranted," said Dr. Gomperts.

A second Accur8 Phase 2/3 clinical trial is also underway to evaluate OBI-1's ability to control bleeding in people with congenital hemophilia A with inhibitors and the safety of this drug in this population.

As part of Inspiration's expanded presence at the WFH World Congress, the company will host a symposium tomorrow
'/>"/>

SOURCE Inspiration Biopharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
2. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
3. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
4. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
5. 2012 Pharmaceutical Diversification Trends, Egypt & Saudi Arabia Pharmaceutical Markets Analyzed in New Research Reports
6. Herborium Group Reports Record 6 Month Revenues
7. Kewaunee Scientific Reports Significantly Improved Results for Fourth Quarter
8. Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status
9. HealthWarehouse.com Reports 82% Year-Over-Year Revenue Growth
10. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
11. China Health Resource Reports on Record Year-End 2011 Results Continuing Strong in 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015  Perrigo Company plc ... its Board of Directors has unanimously rejected the unsolicited ... MYL ), disclosed April 8, 2015, to acquire all ... share. Following a thorough review, advised by its financial ... Proposal substantially undervalues the Company and its future growth ...
(Date:4/21/2015)... , 21. April 2015  CorTechs Labs, ... quantitative Analyse des Hirnvolumens freut sich, eine ... Pharmaunternehmen, bekannt geben zu können. Die Unternehmen ... des Hirnvolumens zusammenarbeiten, der die Identifizierung, Messung ... Patienten mit multipler Sklerose als Ziel hat. ...
(Date:4/21/2015)... WASHINGTON , April 21, 2015 ... the National Minority Quality Forum (NMQF), today ... president of the Pharmaceutical Research and Manufacturers of ... diversity in clinical trials. On behalf of PhRMA, and ... In " campaign to build awareness, start conversations, and ...
Breaking Medicine Technology:Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 2Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 3Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 4Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 5Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 6Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 7Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 8Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 9CorTechs Labs kündigt Partnerschaft für die Bereitstellung umfassender Lösungen zur Quantifizierung des Verlustes von Hirnvolumen bei multipler Sklerose an 2National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 2National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 3
... 18 Misonix, Inc. (Nasdaq: MSON ), ... device technology, which worldwide is used for acute health ... Organization ("GPO") Agreement with First Choice Cooperative ("FCC"), headquartered ... Misonix will offer FCC members the opportunity to purchase ...
... Medical, Inc. (OTC Bulletin Board: AEMD ), ... infectious disease and cancer, today announced that it has ... to expand the opportunity for Aethlon to commercialize its ... centers in India.  The therapeutic focus at each center ...
Cached Medicine Technology:Misonix Announces New GPO Agreement With First Choice Cooperative 2Misonix Announces New GPO Agreement With First Choice Cooperative 3Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs 2Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs 3Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs 4Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs 5
(Date:4/21/2015)... 2015 On April 2, 2015, Elle ... Achieve Kylie Jenner Lips With Disastrous Results,” ... themselves while attempting an at-home lip augmentation ... that creating an airlock around one’s mouth for several ... and achieve Kylie Jenner’s now famous pout. (see: goo.gl/dFQW2L) ...
(Date:4/21/2015)... April 21, 2015 “ ZeroWire ” ... Tech Report, which takes a look at the latest ... Scott Steinberg, a special reporter for NewsWatch and a ... how ZeroWire is a security system and lifestyle management ... there were over 2 million burglaries in 2010. It ...
(Date:4/21/2015)... Lewisville, TX (PRWEB) April 21, 2015 ... (NYSE:ADPT) announced today it is opening its first freestanding ... located in Chandler, Arizona and will be licensed under ... of the Dignity Health and Adeptus Health joint venture. ... Chandler Regional and Mercy Gilbert Medical Centers said the ...
(Date:4/21/2015)... 2015 Wireless Analytics, LLC , ... recognized by the Boston Business Journal as the 25th ... announced at a recent event celebrating the 2015 ... fastest-growing private companies in Massachusetts. , Wireless Analytics was ... that recorded the fastest revenue growth from 2011 through ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 ... 2015” provides comparative analysis on the therapeutic ... R&D pipelines by identifying new targets and ... Complete report with TOC is available @ ... also reviews key players involved in the ...
Breaking Medicine News(10 mins):Health News:Celebrity Cosmetic Surgeon Comments on Report of Teen Girls Injuring Themselves Attempting Kylie Jenner-Inspired Twitter Challenge 2Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 3Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4
... Kids seem to be ignoring message that methamphetamine is ... anti-methamphetamine campaign that utilizes graphic images actually may not ... Montana Meth Project (MMP), created in 2005, featured images ... once." The perceived success of the program had resulted ...
... RALEIGH, N.C., Dec. 11 PRA International, a ... new office in,Mexico City, Mexico. With years ... market in 2005. The region,s existing base ... and infectious diseases,match favorably to PRA,s therapeutic focus. ...
... Drive China,s Psychiatric Drug Market to Reach Nearly $1 Billion ... , , WALTHAM, Mass., Dec. ... and advisory firms focusing on pharmaceutical and healthcare issues, finds ... remain. According to the new special Emerging Markets report entitled ...
... Cytometer System Twice Yearly to Support Innovative Research and Expand ... -Learn More about the Revolutionary Accuri C6 Flow ... , , ANN ARBOR, Mich., ... developing revolutionary bench-top flow cytometer systems, today announced the first ...
... Puppies , , RHINELANDER, Wis., Dec. ... Joshua Tree, California, has been an avid animal lover, trainer and ... Gene,s first dog was no exception. He would have to give ... began Gene,s life long passion for breeding and training animals. ...
... Access to Renal Function and MetLyte 8 Panels for ... UNION CITY, Calif., Dec. 11 Abaxis, Inc. (Nasdaq: ... point-of-care blood analysis systems, today announced that the U.S. ... under CLIA regulations for two additional analytes, Creatine Kinase ...
Cached Medicine News:Health News:Study Questions Value of Anti-Meth Campaign 2Health News:PRA International Expands Operations in Mexico 2Health News:China's Views on Mental Disorders Improving but Challenges Remain 2Health News:China's Views on Mental Disorders Improving but Challenges Remain 3Health News:Researcher Receives Free C6 Flow Cytometer(R) System as First Winner of Accuri Flow Cytometer(R) Creativity Awards Program 2Health News:Researcher Receives Free C6 Flow Cytometer(R) System as First Winner of Accuri Flow Cytometer(R) Creativity Awards Program 3Health News:Researcher Receives Free C6 Flow Cytometer(R) System as First Winner of Accuri Flow Cytometer(R) Creativity Awards Program 4Health News:20,000,000th Phone Order Placed at Doctors Foster & Smith Pet Supplies 2Health News:Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status 2Health News:Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status 3Health News:Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status 4
Used for the introduction of catheters, balloons and other vascular devices....
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used for contralateral access to the iliac artery for interventional procedures after initial wire guide positioning has been established....
Used to introduce balloon, electrode, closed or non-tapered end and other catheters....
Medicine Products: